Jarislowsky, Fraser Ltd’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.67M | Sell |
52,037
-1,410
| -3% | -$172K | 0.04% | 97 |
|
|
2025
Q2 | $6.47M | Sell |
53,447
-700
| -1% | -$78.9K | 0.04% | 98 |
|
|
2025
Q1 | $6.04M | Buy |
54,147
+655
| +1% | +$69.7K | 0.04% | 97 |
|
|
2024
Q4 | $5.21M | Sell |
53,492
-3,275
| -6% | -$349K | 0.03% | 102 |
|
|
2024
Q3 | $6.53M | Buy |
56,767
+39
| +0.1% | +$4.42K | 0.04% | 98 |
|
|
2024
Q2 | $6.04M | Sell |
56,728
-4,585
| -7% | -$460K | 0.04% | 97 |
|
|
2024
Q1 | $5.93M | Sell |
61,313
-2,733
| -4% | -$280K | 0.03% | 107 |
|
|
2023
Q4 | $6.47M | Sell |
64,046
-2,993
| -4% | -$289K | 0.04% | 102 |
|
|
2023
Q3 | $6.83M | Sell |
67,039
-5,324
| -7% | -$540K | 0.04% | 96 |
|
|
2023
Q2 | $7.3M | Sell |
72,363
-8,466
| -10% | -$847K | 0.04% | 96 |
|
|
2023
Q1 | $7.44M | Sell |
80,829
-4,505
| -5% | -$393K | 0.05% | 95 |
|
|
2022
Q4 | $7.74M | Sell |
85,334
-8,906
| -9% | -$750K | 0.05% | 98 |
|
|
2022
Q3 | $7.16M | Sell |
94,240
-12,562
| -12% | -$1.04M | 0.05% | 97 |
|
|
2022
Q2 | $9.03M | Sell |
106,802
-23,803
| -18% | -$2.09M | 0.06% | 97 |
|
|
2022
Q1 | $11.5M | Sell |
130,605
-86,301
| -40% | -$7.47M | 0.06% | 94 |
|
|
2021
Q4 | $19M | Sell |
216,906
-57,630
| -21% | -$4.79M | 0.09% | 83 |
|
|
2021
Q3 | $22.5M | Sell |
274,536
-40,386
| -13% | -$3.63M | 0.11% | 77 |
|
|
2021
Q2 | $28.7M | Sell |
314,922
-124,014
| -28% | -$11M | 0.13% | 73 |
|
|
2021
Q1 | $37.5M | Buy |
438,936
+6,775
| +2% | +$608K | 0.19% | 64 |
|
|
2020
Q4 | $40.8M | Sell |
432,161
-21,243
| -5% | -$1.86M | 0.21% | 62 |
|
|
2020
Q3 | $39.4M | Sell |
453,404
-9,687
| -2% | -$839K | 0.23% | 59 |
|
|
2020
Q2 | $40.4M | Buy |
463,091
+22,443
| +5% | +$1.94M | 0.25% | 58 |
|
|
2020
Q1 | $36.3M | Buy |
440,648
+1,812
| +0.4% | +$162K | 0.26% | 56 |
|
|
2019
Q4 | $41.6M | Buy |
438,836
+706
| +0.2% | +$63.3K | 0.22% | 61 |
|
|
2019
Q3 | $38.1M | Buy |
438,130
+5,360
| +1% | +$481K | 0.21% | 62 |
|
|
2019
Q2 | $39.5M | Sell |
432,770
-44,343
| -9% | -$3.75M | 0.24% | 63 |
|
|
2019
Q1 | $41.1M | Sell |
477,113
-4,598
| -1% | -$369K | 0.26% | 60 |
|
|
2018
Q4 | $37M | Sell |
481,711
-3,553
| -0.7% | -$277K | 0.25% | 61 |
|
|
2018
Q3 | $38M | Buy |
485,264
+1,041
| +0.2% | +$77K | 0.24% | 62 |
|
|
2018
Q2 | $32.8M | Sell |
484,223
-2,174
| -0.4% | -$150K | 0.2% | 66 |
|
|
2018
Q1 | $35.2M | Buy |
486,397
+33,006
| +7% | +$2.51M | 0.22% | 67 |
|
|
2017
Q4 | $34.1M | Buy |
453,391
+221,817
| +96% | +$16.7M | 0.2% | 65 |
|
|
2017
Q3 | $17.8M | Buy |
231,574
+30,639
| +15% | +$2.31M | 0.11% | 85 |
|
|
2017
Q2 | $15M | Buy |
200,935
+16,234
| +9% | +$1.15M | 0.1% | 93 |
|
|
2017
Q1 | $12.3M | Buy |
184,701
+22,425
| +14% | +$1.49M | 0.08% | 102 |
|
|
2016
Q4 | $10.6M | Buy |
162,276
+11,761
| +8% | +$763K | 0.07% | 106 |
|
|
2016
Q3 | $10.6M | Buy |
150,515
+70,662
| +88% | +$5.15M | 0.07% | 103 |
|
|
2016
Q2 | $5.9M | Buy |
79,853
+3,495
| +5% | +$241K | 0.04% | 90 |
|
|
2016
Q1 | $4.96M | Buy |
76,358
+2,094
| +3% | +$142K | 0.03% | 114 |
|
|
2015
Q4 | $5.72M | Buy |
74,264
+1,722
| +2% | +$137K | 0.04% | 111 |
|
|
2015
Q3 | $5.97M | Sell |
72,542
-593
| -0.8% | -$52.8K | 0.04% | 109 |
|
|
2015
Q2 | $6.44M | Buy |
73,135
+949
| +1% | +$87.1K | 0.04% | 107 |
|
|
2015
Q1 | $6.38M | Buy |
72,186
+4,532
| +7% | +$402K | 0.04% | 108 |
|
|
2014
Q4 | $5.62M | Buy |
67,654
+669
| +1% | +$55.5K | 0.03% | 110 |
|
|
2014
Q3 | $5.65M | Sell |
66,985
-1,674
| -2% | -$135K | 0.03% | 108 |
|
|
2014
Q2 | $5.57M | Sell |
68,659
-111
| -0.2% | -$8.73K | 0.03% | 104 |
|
|
2014
Q1 | $5.24M | Sell |
68,770
-1,674
| -2% | -$122K | 0.03% | 107 |
|
|
2013
Q4 | $5.07M | Sell |
70,444
-10,267
| -13% | -$714K | 0.03% | 106 |
|
|
2013
Q3 | $5.55M | Buy |
80,711
+134
| +0.2% | +$8.87K | 0.03% | 104 |
|
|
2013
Q2 | $5.11M | Buy |
+80,577
| New | +$5.24M | 0.03% | 100 |
|
Other funds holding NVS
Jarislowsky, Fraser Ltd's NVS Position: Q3 2025 in Review
Jarislowsky, Fraser Ltd reduced its Novartis (NVS) stake by 2.6% in Q3 2025, selling an estimated $172K and leaving 52,037 shares worth $6.67M. The position accounts for 0.04% of the portfolio, ranked #97.
Jarislowsky, Fraser Ltd first reported a position in NVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $41.6M in Q4 2019. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.
- Jarislowsky, Fraser Ltd held 52,037 shares of Novartis worth $6.67M as of Q3 2025.
- Jarislowsky, Fraser Ltd sold 1,410 Novartis shares in Q3 2025, an estimated $172K.
- Novartis made up 0.04% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #97 holding.
- Jarislowsky, Fraser Ltd first reported a position in Novartis in Q2 2013 and has held it in 50 quarters since.
- Jarislowsky, Fraser Ltd's Novartis position peaked at $41.6M in Q4 2019.
- 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.
Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.